JP2022541772A5 - - Google Patents
Info
- Publication number
- JP2022541772A5 JP2022541772A5 JP2022502485A JP2022502485A JP2022541772A5 JP 2022541772 A5 JP2022541772 A5 JP 2022541772A5 JP 2022502485 A JP2022502485 A JP 2022502485A JP 2022502485 A JP2022502485 A JP 2022502485A JP 2022541772 A5 JP2022541772 A5 JP 2022541772A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- compound
- following formula
- given
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962874531P | 2019-07-16 | 2019-07-16 | |
| US62/874,531 | 2019-07-16 | ||
| PCT/US2020/041876 WO2021011513A1 (en) | 2019-07-16 | 2020-07-14 | Prodrugs in the modulation of interleukin |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022541772A JP2022541772A (ja) | 2022-09-27 |
| JP2022541772A5 true JP2022541772A5 (https=) | 2023-07-24 |
| JP7618642B2 JP7618642B2 (ja) | 2025-01-21 |
Family
ID=71995065
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022502485A Active JP7618642B2 (ja) | 2019-07-16 | 2020-07-14 | インターロイキンの調節におけるプロドラッグ |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US12528782B2 (https=) |
| EP (1) | EP3999499B1 (https=) |
| JP (1) | JP7618642B2 (https=) |
| KR (1) | KR20220034853A (https=) |
| CN (1) | CN114364665B (https=) |
| ES (1) | ES2991171T3 (https=) |
| WO (1) | WO2021011513A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115466289A (zh) * | 2021-06-11 | 2022-12-13 | 爱科诺生物医药(香港)有限公司 | 具有tyk2抑制活性的化合物，包含其的药物组合物，及其应用 |
| CN117362343A (zh) * | 2022-07-08 | 2024-01-09 | 爱科诺生物医药(香港)有限公司 | 具有选择性抑制tyk2/jak1活性的化合物，包含其的药物组合物，及其应用 |
| CN118593504B (zh) * | 2024-06-03 | 2025-03-18 | 北京大学第三医院（北京大学第三临床医学院） | 氘可来昔替尼或其盐在制备pvns药物方面的新用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT3495358T (lt) | 2012-11-08 | 2022-05-25 | Bristol-Myers Squibb Company | Amidais pakeisti heterocikliniai junginiai, naudingi kaip il-12, il-23 ir (arba) ifn alfa atsako moduliatoriai |
| TWI582077B (zh) | 2013-11-07 | 2017-05-11 | 必治妥美雅史谷比公司 | 作爲ＩＬ－１２、ＩＬ－２３及／或ＩＦＮα反應調節劑之經烷基－醯胺取代之吡啶化合物 |
| PL3125894T3 (pl) | 2014-04-01 | 2021-02-08 | Merck Sharp & Dohme Corp. | Proleki inhibitorów odwrotnej transkryptazy hiv |
| EP3625214B1 (en) | 2017-05-16 | 2022-07-06 | Vertex Pharmaceuticals Incorporated | Deuterated pyridone amides and prodrugs thereof as modulators of sodium channels |
| JP7631193B2 (ja) * | 2018-10-22 | 2025-02-18 | アルミス インコーポレイテッド | Ｔｙｋ２阻害剤およびその使用 |
-
2020
- 2020-07-14 WO PCT/US2020/041876 patent/WO2021011513A1/en not_active Ceased
- 2020-07-14 CN CN202080063583.6A patent/CN114364665B/zh active Active
- 2020-07-14 US US17/627,169 patent/US12528782B2/en active Active
- 2020-07-14 EP EP20753523.8A patent/EP3999499B1/en active Active
- 2020-07-14 KR KR1020227004691A patent/KR20220034853A/ko not_active Ceased
- 2020-07-14 ES ES20753523T patent/ES2991171T3/es active Active
- 2020-07-14 JP JP2022502485A patent/JP7618642B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022541772A5 (https=) | ||
| JP2020502268A5 (https=) | ||
| JP2024071370A5 (https=) | ||
| JP2018536634A5 (https=) | ||
| HRP20210252T1 (hr) | Heterociklički amidi kao inhibitori kinaze | |
| JP2012500805A5 (https=) | ||
| JP2020532585A5 (https=) | ||
| JP2013514980A5 (https=) | ||
| JP2021528421A5 (https=) | ||
| JP2019515924A5 (https=) | ||
| JP2022519239A5 (https=) | ||
| RU2019122815A (ru) | Ингибиторы гистонацетилазы | |
| JP2019527724A5 (https=) | ||
| JP2006508966A5 (https=) | ||
| JP2019214626A5 (https=) | ||
| WO2015138933A1 (en) | Solid state forms of dolutegravir sodium | |
| JP2022526553A5 (https=) | ||
| JP2019151627A5 (https=) | ||
| US10584100B2 (en) | Solid state forms of netarsudil mesylate | |
| JP2021091670A5 (https=) | ||
| JP2006523239A5 (https=) | ||
| JP2016521695A5 (https=) | ||
| JP2025003673A5 (https=) | ||
| JP2019507120A5 (https=) | ||
| JP2000026494A5 (https=) |